Does Semaglutide Expire? Shelf Life, Storage & Potency Guide

Ozempic (for type 2 diabetes) and Wegovy (for weight management) are liquid formulations engineered for maximum shelf stability. Novo Nordisk's proprietary buffer system, precise pH control, and pharmaceutical-grade excipients protect the peptide from degradation far longer than a compounding pharmacy can achieve.

Unopened pens stored at 2-8°C remain potent until the printed expiration date. That date is typically 24 months from manufacture, though it can vary by batch. After the first injection or after removing the pen from refrigeration, it remains stable for 56 days at room temperature (up to 30°C / 86°F). This 56-day window is longer than tirzepatide pens, which allow only 21 days at room temperature.

Never freeze an Ozempic or Wegovy pen. The freeze-thaw cycle disrupts the protein structure and can alter the injection mechanism. If a pen has been frozen, even briefly, discard it. Novo Nordisk's prescribing information is explicit on this point: frozen pens should not be used, even if thawed.

The 56-day room-temperature stability is clinically validated. Novo Nordisk submitted accelerated stability data to the FDA demonstrating that semaglutide in the pen formulation retains greater than 95% potency for 8 weeks at 30°C (Novo Nordisk Ozempic Prescribing Information, 2024).

Compounded semaglutide comes in two forms: lyophilized powder requiring reconstitution, and pre-mixed liquid solutions. Each carries a beyond-use date (BUD) assigned by the compounding pharmacy.

Lyophilized compounded semaglutide typically receives a 6-month BUD when stored at 2-8°C. Pre-mixed liquid formulations get 28 to 45 days depending on the pharmacy's stability data. These dates are often based on USP general chapter standards rather than product-specific accelerated stability testing, so they tend to be conservative.

The practical gap between manufacturer and compounded products matters. An Ozempic pen can sit in your refrigerator for two years and remain fully potent. A compounded vial has a fraction of that window. If you are switching from brand-name to compounded semaglutide, plan your purchasing around how fast you will use each vial. A cheaper vial that expires before you finish it saves nothing.

For guidance on mixing compounded semaglutide, see how much bacteriostatic water for semaglutide.

Adding bacteriostatic water to lyophilized semaglutide powder starts the degradation clock. The peptide is now in aqueous solution, and every chemical breakdown pathway activates simultaneously.

With bacteriostatic water (containing 0.9% benzyl alcohol), reconstituted semaglutide lasts approximately 28 days at 2-8°C. The benzyl alcohol suppresses bacterial growth, allowing multiple draws from the same vial. Without that preservative, using plain sterile water for injection, the solution is safe for only 24 to 48 hours.

Each needle puncture through the rubber stopper introduces potential contamination. After 15 to 20 punctures, the stopper may no longer seal properly. Use our semaglutide dosage calculator to calculate exact draw volumes and minimize unnecessary vial entries.

For a broader look at reconstituted peptide timelines across multiple compounds, see how long do reconstituted peptides last.

Asparagine residues in the semaglutide peptide chain convert to aspartate through deamidation. This is the dominant degradation pathway for GLP-1 receptor agonists in aqueous solution.

The reaction rate roughly doubles with every 10°C temperature increase. At 2-8°C, deamidation is slow enough that the peptide retains greater than 90% potency for 28 days in solution. At 25°C, that same level of degradation occurs within 7 to 10 days. At 37°C, significant potency loss happens in 3 to 5 days.

A comprehensive review of peptide pharmaceutical stability identified deamidation as the most common chemical instability, affecting virtually every peptide containing asparagine-glycine sequences (Manning et al., Pharm Res, 2010). Semaglutide's sequence includes multiple asparagine residues, making it susceptible.

Methionine and tryptophan residues in semaglutide are vulnerable to oxidation. Dissolved oxygen, UV light, and trace metals all catalyze the reaction.

Oxidized semaglutide binds less effectively to the GLP-1 receptor. Research on GLP-1 receptor agonist stability found that oxidation of a single methionine residue reduced receptor binding affinity by 40-60% (Houen & Jakobsen, J Pharm Sci, 2019). That reduction translates directly to a weaker dose.

A vial sitting on a countertop in direct sunlight for 8 hours can lose 5-8% potency from photo-oxidation alone. Combine that with heat exposure if the room is warm, and you compound the damage. Store vials in the original carton, in amber glass, or wrapped in aluminum foil. Never leave semaglutide on a windowsill, bathroom counter, or anywhere exposed to natural light.

When semaglutide molecules unfold or partially degrade, they can clump into aggregates. These appear as cloudiness, visible particles, or a gel-like film in the solution.

Aggregated semaglutide is not just less potent. It is potentially immunogenic. The immune system can recognize peptide aggregates as foreign and mount an antibody response. Anti-drug antibodies against semaglutide could reduce the efficacy of future doses or, in rare cases, trigger allergic reactions. In the STEP trials, anti-semaglutide antibody formation occurred in approximately 1-2% of subjects at therapeutic doses (Wilding et al., NEJM, 2021). Degraded formulations with higher aggregate content could push that number higher.

Temperature cycling accelerates aggregation. Every time you take a vial out of the fridge, warm it in your hands, draw a dose, and return it, you create a micro-cycle that stresses the peptide. Minimize handling time. Draw your dose and return the vial within 60 seconds.

Potency loss follows an exponential decay pattern. Early degradation is slow; later degradation accelerates as breakdown products catalyze further reactions.

At refrigerator temperature, reconstituted semaglutide stays within the pharmaceutical threshold (greater than 90% potency) for approximately 28 days. At room temperature, it drops below that threshold by day 14 to 18. Pre-filled pens perform better because Novo Nordisk's formulation includes stabilizing excipients that slow all three degradation pathways simultaneously.

For context on how tirzepatide compares, its reconstituted shelf life is also 28 days refrigerated, but pen stability at room temperature is only 21 days versus semaglutide's 56.

The expiration date is printed on the pen label and on the outer carton. It appears as "EXP" followed by a month and year (e.g., EXP 03/2028). This means the pen is potent through the last day of that month when stored at 2-8°C.

Two separate timelines apply. The printed expiration date governs the unopened pen in the refrigerator. The 56-day clock starts the moment you remove the pen from the fridge or give your first injection, whichever comes first. Both timelines matter. If your pen's printed date is next month but you took it out of the fridge 50 days ago, you have 6 days left regardless of the printed date.

Write the "first use" date on the pen with a permanent marker. Without it, you are guessing. A study on medication adherence found that patients who labeled their injectable medications with start dates were 34% more likely to discard expired product on time (Patel et al., Patient Prefer Adherence, 2013).

Compounding pharmacies print a beyond-use date (BUD) on the vial label. This is not the same as a manufacturer expiration date. The BUD is typically more conservative because it is based on general USP standards rather than product-specific stability testing.

A compounded vial might read "BUD: 09/2026" for lyophilized powder or "BUD: 04/14/2026" for pre-mixed liquid. The liquid BUD counts from the compounding date, not from when you received it. Check how many days remain when your order arrives. If a pre-mixed liquid vial arrives with only 15 of its 28-day window remaining, you need to use it faster or request fresher batches.

For lyophilized vials, the BUD applies to the unopened powder. Once you reconstitute, a new 28-day window begins (with bacteriostatic water). Write the reconstitution date on the vial. This date overrides the printed BUD if it comes first.

Every semaglutide product carries a lot number linking it to a specific manufacturing batch. If Novo Nordisk or a compounding pharmacy issues a recall, the lot number identifies affected products.

Record your lot number when you start a new pen or vial. Keep a simple note on your phone: product name, lot number, start date. In the event of a recall, this information lets you confirm immediately whether your product is affected. The FDA's MedWatch system publishes recall notices searchable by lot number.

Cloudiness or turbidity. Fresh semaglutide solution is clear and colorless. Any haziness or opalescence indicates protein aggregation. Do not inject a cloudy solution.

Visible particles. Hold the vial or pen up to a light source and gently swirl. Floating specks, flakes, or fibers signal contamination or aggregation. A single tiny fiber could be a stopper fragment, but multiple particles mean the product should be discarded.

Color change. Semaglutide solution is colorless to very slightly yellow. Any shift toward amber, brown, or pink indicates oxidation or chemical breakdown. Discard immediately.

Gel formation. In advanced degradation, peptide aggregates can form a gel-like layer on vial walls or at the bottom. This represents severe structural damage. The peptide is not salvageable.

The most telling sign of degraded semaglutide is reduced clinical effect. If you have been on a stable dose producing consistent appetite suppression and weight loss, and those effects suddenly weaken without any change in your habits, the product may have lost significant potency.

Consider the dose-response data. In the STEP 1 trial, 2.4 mg weekly semaglutide produced 14.9% mean body weight reduction versus 2.4% with placebo (Wilding et al., NEJM, 2021). A 15-20% potency loss in your vial effectively drops your 2.4 mg dose to 1.9-2.0 mg. That gap could reduce your weekly weight loss from 0.5 kg to 0.2 kg or less.

If you are using semaglutide for type 2 diabetes and notice blood glucose readings creeping upward on a previously stable dose, degraded medication is one possible explanation. Check the vial visually, confirm the reconstitution date, and contact your prescriber if suspicion persists. For other reasons weight loss may stall, see why am I not losing weight on semaglutide.

Degradation products can lower the pH of semaglutide solution, increasing tissue irritation at the injection site. If your injections begin stinging or burning more than usual with a previously tolerated preparation, the solution chemistry may have shifted.

Aggregated peptide fragments can also trigger localized immune responses, producing more redness, swelling, or induration than you experienced with fresh product. This is not definitive proof of expiration, but it warrants caution. Switch to a new vial or pen and see if the reaction resolves.

Expired semaglutide is not typically toxic. The peptide breaks down into smaller inactive fragments and altered amino acids. The body recognizes and clears these degradation products without adverse effects in most cases.

The real consequence is reduced efficacy. A pen or vial that has lost 20% potency delivers 20% less active drug per injection. For someone on a weight management protocol, that shortfall can stall progress without an obvious cause. You eat the same, exercise the same, inject on schedule, yet the scale stops moving.

A study on the stability of GLP-1 receptor agonists found that degraded formulations showed reduced receptor binding but no increase in adverse events compared to fresh formulations (Kapitza et al., 2015). The risk is therapeutic failure, not poisoning.

Three scenarios cross the line from "weaker dose" to "potential harm."

Bacterial contamination. A reconstituted vial stored beyond 28 days, especially one mixed with sterile water instead of bacteriostatic water, can harbor bacteria. Injecting contaminated solution risks abscess formation, cellulitis, or systemic infection. In severe cases, heavily contaminated injections can cause sepsis. Bacteriostatic water's benzyl alcohol preservative reduces but does not eliminate this risk after extended storage.

Aggregate-driven immune response. Peptide aggregates formed during prolonged storage can trigger antibody formation. Anti-drug antibodies against semaglutide could reduce the effectiveness of future doses or cause allergic reactions ranging from injection site swelling to, in rare cases, anaphylaxis. The SUSTAIN and STEP trials reported anti-semaglutide antibody formation in approximately 1-2% of treated subjects at standard doses. Degraded formulations with higher aggregate content could increase that percentage.

Unpredictable dosing in multi-dose vials. If a vial has degraded unevenly, with more concentrated solution near the bottom and dilute solution near the top, individual doses become inconsistent. One draw might deliver 70% of the intended dose. The next might deliver 110%. For diabetic patients relying on semaglutide for glycemic control, these swings can cause dangerous blood sugar fluctuations.

Ozempic/Wegovy pens: Refrigerate at 2-8°C until first use. After the first injection, the pen can remain at room temperature (up to 30°C) for 56 days. Do not return a room-temperature pen to the fridge and assume the clock resets. The 56-day countdown begins when the pen first leaves refrigeration.

Lyophilized powder: Store at -20°C for maximum longevity (24-36 months). A standard kitchen freezer works. If freezer space is unavailable, 2-8°C is acceptable for the duration of the printed BUD. Never store vials in the refrigerator door, where temperature fluctuates 5-8°C with each opening.

Reconstituted solution: Refrigerate at 2-8°C immediately after mixing. Place the vial in the main body of the refrigerator on a dedicated shelf. A simple refrigerator thermometer costs a few dollars and confirms your fridge is actually at 2-8°C. Consumer refrigerators frequently run warmer than the dial indicates.

For step-by-step reconstitution technique, see how much bacteriostatic water for semaglutide. For broader storage principles, consult the peptide storage guide.

UV and visible light catalyze oxidation of tryptophan and methionine residues. Always store semaglutide in its original carton, in an amber vial, or wrapped in aluminum foil.

Novo Nordisk packages Ozempic and Wegovy pens in opaque cartons for this reason. Removing the pen from its carton and leaving it on a kitchen counter exposes it to ambient light throughout the day. Even indoor fluorescent lighting contributes to photo-oxidation over weeks. Keep the pen in its box between injections.

For compounded vials, request amber glass from your pharmacy. Clear glass vials transmit the UV wavelengths (290-320 nm) most responsible for peptide oxidation. If your vial is clear glass, wrap it in foil and store in a closed container inside the fridge.

Every needle entry into a vial is a potential contamination event. Sterile technique determines whether your vial lasts the full 28 days or becomes a bacterial culture.

Swab the rubber stopper with a fresh alcohol pad before every needle insertion. Wait 10 seconds for the alcohol to dry. Use a new needle for each draw. Do not touch the needle to any surface before piercing the stopper. Wash hands thoroughly before handling vials and syringes.

If you reconstitute with sterile water (no preservative), draw all planned doses immediately into separate sterile syringes and store them individually in the refrigerator. Do not re-enter a sterile-water vial after 24 hours. Bacteriostatic water is strongly preferred for any multi-dose vial. For details on bacteriostatic water storage, see does bacteriostatic water need to be refrigerated.

Semaglutide pens have a generous travel window. The 56-day room temperature stability means you can carry an Ozempic or Wegovy pen in your bag for nearly two months without refrigeration, as long as the temperature stays below 30°C.

For reconstituted vials, use a medical-grade insulated bag with gel packs pre-chilled to 2-8°C. Place a small towel between the gel pack and the vial to prevent accidental freezing. Direct contact with an ice pack can freeze the solution, destroying the peptide.

For air travel, carry semaglutide in your cabin bag with a prescription label or letter from your prescriber. Checked luggage is exposed to extreme temperature swings in the cargo hold. TSA permits injectable medications with documentation. The peptide safety guide covers travel protocols in greater detail.